SNP | RefSeq number | Major/minor allele | CEU allele frequencies according to HapMap | MAF in controls | MAF in patients with WG* | p Value |
1 | rs588997 | G/A | 0.64/0.36 | 0.37 | 0.34 | 0.198 |
26 | rs1367728 | G/A | 0.90/0.10 | 0.12 | 0.14 | 0.323 |
2 | rs9469341 | A/G | 0.88/0.12 | 0.16 | 0.08 | 0.0001 |
27 | rs9277341 | T/C | 0.78/0.22 | 0.28 | 0.13 | 6.01×10−10 |
3 | rs3117228 | C/A | 0.68/0.32 | 0.30 | 0.08 | 3.64×10−21 |
28 | rs2281390 | C/A | 0.84/0.16 | 0.18 | 0.23 | 0.030 |
4 | rs2064474 | C/T | 0.79/0.21 | 0.24 | 0.05 | 2.323×10−19 |
5 | rs3130215 | G/A | 0.56/0.44 | 0.41 (A) | 0.38 (G) | 1.946×10−13 |
29 | rs11751659 | A/G | 0.85/0.15 | 0.13 | 0.15 | 0.492 |
6 | rs3130233 | T/C | 0.51/0.49 | 0.50 | 0.39 | 0.0001 |
7 | rs3129269 | G/T | 0.65/0.35 | 0.37 | 0.26 | 3.35×10−5 |
8 | rs2294478 | G/T | 0.59/0.41 | 0.46 | 0.49 | 0.428 |
9 | rs2294477 | C/G | 0.59/0.41 | 0.44 (G) | 0.43 (C) | 4.72×10−6 |
10 | rs2294473 | G/C | 0.52/0.48 | 0.46 | 0.47 | 0.522 |
11 | rs9277882 | T/G | 0.62/0.38 | 0.44 | 0.34 | 0.0004 |
12 | rs7754362 | A/C | 0.69/0.31 | 0.43 | 0.34 | 0.0019 |
13 | rs3129208 | T/C | 0.55/0.45 | 0.37 | 0.48 | 0.0001 |
14 | rs9277916 | C/G | 0.69/0.31 | 0.32 | 0.30 | 0.283 |
15 | rs3116956 | G/A | 0.65/0.35 | 0.33 | 0.45 | 4.96×10−6 |
16 | rs734181 | G/C | 0.78/0.22 | 0.18 | 0.15 | 0.116 |
17 | rs1799910 | G/A | 0.55/0.45 | 0.49 | 0.31 | 7.71×10−10 |
18 | rs2855423 | C/T | 0.69/0.31 | 0.26 | 0.42 | 7.63×10−10 |
19 | rs9277934 | C/T | 0.70/0.30 | 0.31 | 0.28 | 0.276 |
20 | rs421446 | T/C | 0.74/0.26 | 0.27 | 0.14 | 3.78×10−9 |
32 | rs213210 | T/C | 0.94/0.06 | 0.06 | 0.01 | 0.0001 |
33 | rs213209 | G/A | 0.75/0.25 | 0.27 | 0.14 | 5.45×10−9 |
34 | rs213208 | C/A | 0.78/0.22 | 0.22 | 0.08 | 2.14×10−12 |
35 | rs2854028 | G/A | 0.77/0.23 | 0.23 | 0.22 | 0.779 |
21 | rs9277936 | T/A | 0.75/0.25 | 0.25 | 0.26 | 0.611 |
22 | rs213213 | G/A | 0.68/0.32 | 0.31 | 0.49 | 2.26×10−10 |
23 | rs213194 | A/G | 0.73/0.27 | 0.24 | 0.42 | 6.82×10−11 |
30 | rs9277952 | G/A | 0.64/0.36 | 0.11 | 0.07 | 0.0059 |
31 | rs460568 | G/A | 0.81/0.19 | 0.15 | 0.18 | 0.154 |
24 | rs213199 | C/T | 0.67/0.33 | 0.36 | 0.30 | 0.031 |
25 | rs213207 | A/G | 0.52/0.48 | 0.50 | 0.47 | 0.288 |
*MAF from patients with WG and p values are given for the entire cohort (n = 282). For differential data from the original patient cohort (Jagiello et al11), the new ANCA-positive cohort and the ANCA-negative cohort see supplementary table 1.
ANCA, antineutrophil cytoplasmic antibodies; MAF, minor allele frequency.